Dianthus Therapeutics(DNTH)
$89.30+0.49 (+0.55%)
DNTH
Dianthus Therapeutics earnings date
$89.30
At close:+0.49 (+0.55%)
Want to see DNTH full AI Analyst Report?
Dianthus Therapeutics (DNTH) Q3 2021 Earnings Report
446 Followers
DNTH Q3 2021 EPS Results
- Actual EPS
- -$4.80
- Consensus EPS
- -$5.26
- Beat/Miss
- Beat by +$0.46
- One Year Ago EPS
- -$5.92
DNTH Q3 2021 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2021
- Date
- 11/04/2021
- Time
- Before Open
- Conference Call
- Thursday, November 4, 2021
DNTH Upcoming Earnings
Dianthus Therapeutics's next earnings date is estimated for March 16, 2027, based on past reporting schedules.
Q3 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DNTH Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 16, 2027 | 2026 (Q4) | -0.96- | -1.43 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | -0.94-0.81 | -0.97 | 16.49% (+0.16) | |
| Aug 04, 2026 | 2026 (Q2) | -0.85-0.90 | -0.88 | -2.27% (-0.02) | |
| May 05, 2026 | 2026 (Q1) | -1.07-0.85 | -0.82 | -3.66% (-0.03) | |
| Mar 09, 2026 | 2025 (Q4) | -1.01-1.43 | -0.81 | -76.54% (-0.62) | |
| Nov 05, 2025 | 2025 (Q3) | -0.87-0.97 | -0.74 | -31.08% (-0.23) | |
| Aug 07, 2025 | 2025 (Q2) | -0.87-0.88 | -0.51 | -72.55% (-0.37) | |
| May 12, 2025 | 2025 (Q1) | -0.85-0.82 | -0.54 | -51.85% (-0.28) | |
| Mar 11, 2025 | 2024 (Q4) | -0.85-0.81 | -0.71 | -14.08% (-0.10) | |
| Nov 07, 2024 | 2024 (Q3) | -0.59-0.74 | -3.78 | 80.42% (+3.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
